Transplantation, AutologousPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationStem Cell TransplantationHematopoietic Stem Cell MobilizationMelphalanTransplantation ConditioningCombined Modality TherapyMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactorLeukapheresisTransplantation, HomologousAntigens, CD34CyclophosphamideBlood Component RemovalTreatment OutcomeHematologic NeoplasmsLymphoma, Non-HodgkinStem CellsEtoposideMyeloablative AgonistsRemission InductionHematopoietic Stem CellsThiotepaSalvage TherapyBusulfanCarmustineBone Marrow TransplantationHodgkin DiseaseRecurrenceCytarabineDisease-Free SurvivalAntineoplastic Agents, AlkylatingVincristineGraft SurvivalGraft vs Host DiseaseIfosfamideAmyloidosisSurvival RateBone Marrow PurgingDoxorubicinRetrospective StudiesSurvival AnalysisDexamethasoneCytophagocytosisHematopoiesisWhole-Body IrradiationNeoplasmsTime FactorsPrednisoneFollow-Up StudiesAntineoplastic AgentsCarboplatinCord Blood Stem Cell TransplantationTissue DonorsLymphomaPrognosisTransplantation ChimeraLeukemia, Myeloid, AcuteBlood Cell CountProspective StudiesPlatelet CountLymphoma, T-CellBlood Transfusion, AutologousRecombinant ProteinsLymphoma, Mantle-CellEmbryonic Stem CellsAntibodies, Monoclonal, Murine-DerivedFeasibility StudiesMesenchymal Stem Cell TransplantationPodophyllotoxinNeoplasm, ResidualBoronic AcidsAdult Stem CellsBlood CellsHistocompatibilityPyrazinesImmunosuppressive AgentsHistocompatibility TestingLymphoma, FollicularInfectionFatal OutcomeLymphoma, T-Cell, PeripheralT-LymphocytesBreast NeoplasmsAutograftsMyelodysplastic SyndromesThalidomideLeukemiaVidarabineCell SeparationBone MarrowFlow CytometryLiver TransplantationMitoxantroneLeukocytes, MononuclearImmunophenotypingCell DifferentiationIdarubicin